FDA Doubles Down On Rejecting Over-The-Counter CBD Without More Study

The message was a familiar one

Federal food and drug regulators on Tuesday addressed the hemp industry directly for the first time since stakeholders asked for feedback regarding CBD safety back in 2019.

But the message was a familiar one.

Grail Sipes, acting cannabis-product committee chair with the U.S. Food and Drug Administration, reiterated the agency’s position that it needs additional CBD research and safety data before it can be considered for uses beyond prescription drugs, such as a food additive or dietary supplement.

“We continue to underscore the need for evidence to support the science, safety profile and quality of CBD and cannabis-derived products,” Sipes told the National Industrial Hemp Council in Washington DC.

To Read The Rest Of This Article On Hemp Industry Daily, Click Here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

CHAMPS Smoke Shop Report, or ‘CSS’, online source for the updates and innovations on the smoke shop scene. News and information are geared strictly to accessories retail channels, with distribution limited to retailers that Smoke Shop products and wholesalers.


Stay informed with the most up-to-date industry news to help you grow your business: subscribe to our newsletter below!

  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag(‘js’, new Date());gtag(‘config’, ‘UA-101727731-3’);

To Top